Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:14 AM UTC
| NCT Number | NCT06428396 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | March 24, 2026 (3 weeks ago) |
As of April 17, 2026: Clinical trial NCT06428396 is currently recruiting participants. This clinical trial study for breast cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06428396 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06428396 was last updated 3 weeks ago (March 24, 2026). HelloStudys verifies this status automatically.